Skip to main content

Table 2 Changes in alveolar bone height (mm) at week 12

From: Efficacy and safety of rhBMP/β-TCP in alveolar ridge preservation: a multicenter, randomized, open-label, comparative, investigator-blinded clinical trial

 

Test group (N = 41)

Control group (N = 43)

Change from baseline at week 12

 Mean ± SD

− 0.51 ± 0.94

− 1.50 ± 1.26

 LS mean ± SE

− 0.50 ± 0.20

− 1.42 ± 0.19

 Median

− 0.17

− 1.32

 Min, max

− 4.52, 0.44

− 5.63, 0.25

p value*

< 0.0001 (w)

< 0.0001 (w)

LS mean difference (SE) with control group

0.92 (0.25)

 

 95% CI for the LS mean difference

[0.43, 1.41]

 

p value

0.0004

 
  1. SD standard deviation, LS mean least-square mean, SE standard error, CI confidence interval
  2. *Testing for within-treatment group (paired t test (t) or Wilcoxon’s signed-rank test (w))
  3. Testing for between-treatment group (ANCOVA model with baseline value and trial center as covariates)